molina healthcare inc. - MOH
MOH
Close Chg Chg %
282.76 11.98 4.24%
Closed Market
294.74
+11.98 (4.24%)
Volume: 705.63K
Last Updated:
Nov 20, 2024, 3:59 PM EDT
Company Overview: molina healthcare inc. - MOH
MOH Key Data
| Open $283.95 | Day Range 283.50 - 294.80 |
| 52 Week Range 272.69 - 423.92 | Market Cap $16.16B |
| Shares Outstanding 57.20M | Public Float 56.55M |
| Beta 0.59 | Rev. Per Employee N/A |
| P/E Ratio 14.34 | EPS $19.76 |
| Yield 0.00% | Dividend N/A |
| EX-DIVIDEND DATE | SHORT INTEREST N/A |
| AVERAGE VOLUME 930.12K |
MOH Performance
| 1 Week | 0.10% | ||
| 1 Month | 1.70% | ||
| 3 Months | -14.80% | ||
| 1 Year | -19.85% | ||
| 5 Years | 119.01% |
MOH Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
17
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
Snapshot
| Average Recommendation | OVERWEIGHT | Average Target Price | 368.571 | |
| Number of Ratings | 17 | Current Quarters Estimate | 5.768 | |
| FY Report Date | 12 / 2024 | Current Year's Estimate | 23.21 | |
| Last Quarter’s Earnings | 6.01 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 20.88 | Next Fiscal Year Estimate | 25.906 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 15 | 13 | 15 | 15 |
| Mean Estimate | 5.77 | 6.62 | 23.21 | 25.91 |
| High Estimates | 6.15 | 7.25 | 23.75 | 27.20 |
| Low Estimate | 3.84 | 5.94 | 19.38 | 21.90 |
| Coefficient of Variance | 9.66 | 6.23 | 4.62 | 4.49 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 5 | 5 | 6 |
| OVERWEIGHT | 2 | 2 | 2 |
| HOLD | 9 | 9 | 9 |
| UNDERWEIGHT | 1 | 1 | 1 |
| SELL | 0 | 0 | 0 |
| MEAN | Overweight | Overweight | Overweight |
SEC Filings for Molina Healthcare Inc. - MOH
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Molina Healthcare Inc. - MOH
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Jul 3, 2024 | Daniel Cooperman Director | 5,977 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $292.16 per share | 1,746,240.32 |
| Jul 3, 2024 | Jeff D. Barlow Chief Legal Officer | 71,488 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $252.71 per share | 18,065,732.48 |
| Jul 3, 2024 | Stephen H. Lockhart Director | 2,442 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $292.16 per share | 713,454.72 |
| Jul 3, 2024 | Ronna E. Romney Director | 17,133 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $292.16 per share | 5,005,577.28 |
| Jul 3, 2024 | Richard M. Schapiro Director | 11,531 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $292.16 per share | 3,368,896.96 |
| Jul 3, 2024 | Debra Bacon EVP, Medicaid | 6,689 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $252.71 per share | 1,690,377.19 |
| Jul 3, 2024 | Debra Bacon EVP, Medicaid | 6,505 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $292.16 per share | 1,900,500.80 |
| Jul 3, 2024 | Steven J. Orlando Director | 19,025 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $292.16 per share | 5,558,344.00 |
| Jul 3, 2024 | Dale B. Wolf Director | 15,191 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $292.16 per share | 4,438,202.56 |
| Jul 3, 2024 | Richard C. Zoretic Director | 6,647 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $292.16 per share | 1,941,987.52 |
| Jul 3, 2024 | James E. Woys Chief Operating Officer | 53,682 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $252.71 per share | 13,565,978.22 |
| Jul 3, 2024 | Barbara L. Brasier Director | 3,876 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $292.16 per share | 1,132,412.16 |
| Mar 6, 2024 | Joseph M. Zubretsky President & CEO; Director | 333,217 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $387.21 per share | 129,024,954.57 |
| Mar 6, 2024 | Joseph M. Zubretsky President & CEO; Director | 349,952 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $387.21 per share | 135,504,913.92 |
| Mar 6, 2024 | Joseph M. Zubretsky President & CEO; Director | 360,591 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $387.21 per share | 139,624,441.11 |
| Mar 6, 2024 | Joseph M. Zubretsky President & CEO; Director | 392,660 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $387.21 per share | 152,041,878.60 |
| Mar 6, 2024 | Maurice S. Hebert Chief Accounting Officer | 10,058 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $387.21 per share | 3,894,558.18 |
| Mar 6, 2024 | Maurice S. Hebert Chief Accounting Officer | 9,608 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $387.21 per share | 3,720,313.68 |
| Mar 6, 2024 | James E. Woys Chief Operating Officer | 63,613 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $387.21 per share | 24,631,589.73 |
| Mar 6, 2024 | James E. Woys Chief Operating Officer | 58,964 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $387.21 per share | 22,831,450.44 |